Frankfurt am Main, November 13, 2013 -- Moody's Investors Service has today changed to negative from stable the outlook on Grifols S.A. ("Grifols" or "the company") ratings. Concurrently, the Ba2 Corporate Family Rating (CFR), the Ba2-PD Probability of Default Rating as well as the Ba1 senior secured and B1 senior unsecured ratings to bank and bond instruments respectively of Grifols and its guaranteed subsidiary have been affirmed. This rating action follows the announcement to acquire Novartis diagnostic business unit for US$1.675 billion.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.